Supply shortages of Wegovy and others may impact successful treatment
#DiabetesCare #PatientFirst #KidneyProtection #HeartHealth #PersonalizedMedicine Medication Changes Heart & Kidney First Earlier Use of SGLT2 Inhibitors Medicines like dapagliflozin and empagliflozin (SGLT2 inhibitors) are now offered earlier in treatment not just after metformin fails
The key advantage is improved tolerability and higher long-term adherence rates, which often lead to better cumulative outcomes
Absorption of fluid by the midgut of Rhodnius
From a biological point of view, it can be predicted that exposure to ionizing radiation during missions beyond Low Earth Orbit (LEO) will affect the human body in undesirable ways, e.g., increasing the risks of cataracts, cardiovascular and central nervous system diseases, carcinogenesis, as well as accelerated ageing
A short questionnaire health history and goals